Performance Audit of Prevention and Control of Diseases Programme in Assam fort he period 1996-97 to 2000-2001 revealed following main findings with reference to National Programme for Control of Blindness:

1. Central grant of Rs.1.57 crore out of Rs. 1.59 crore remained unutilised during 1996-97 to 2000-2001 besides non-utilisation of Rs.86.57 lakh out of the grants of Rs.1.57 crore released by Government of India during 1992-93 to 1995-96.
2. Funds provided during 1996-2001 by Government of India for development of district hospitals, PHCs, Mobile Ophthalmic Units and construction of eye wards (Rs.16 lakh), operation theatres (Rs. 60 lakh) in the districts, IEC (Rs.19 lakh); Renovations and Furnishing (Rs. 18 lakh) were not utilised for the purpose.
3. Records showing number of cases where vision was restored/not restored after surgery, screening of patients for refractive errors, provision for spectacles and rehabilitation of incurably blind were not maintained. Similarly, this performance audit revealed following main findings with reference to National Programme for Control of National Tuberculosis Control Programme:
4. Out of Rs. 2.54 crore provided by Government of India in cash during 1997-98 to 2000-2001 the department had not released Rs. 0.70 crore indicating that funds were diverted for other purposes instead of utilisation on the programme.
5. The department spent Rs.0.13 crore in excess of ceiling of funds for purchase of anti TB drugs during 2000-2001.
6. Targets and achievements for setting up TB units, TB dispensaries/chest clinics and microscopy centres during 1996-97 to 2000-2001 were not on record.
7. In 17 District Tuberculosis Centres 8 posts of Medical Officers and 52 posts of paramedical staff were lying vacant. Besides, there was no record of utilisation of 656 TB beds in government hospitals between 1996-97 and 2000-2001.
8. Contrary to Government of India orders (January 1999) the DHS had purchased Rifampicine Capsules and Pyrazinamide tablets valued at Rs. 0.54 crore during January 1999 to October 2000 out of the grants received from Government of India. In DTC Karbi - Anglong out of 3 lakh Rifampicine capsules received in October 1995 against indents placed by DGHS, shelf life of 1.07 lakh capsules valued at Rs.6.42 lakh expired in October 1996 due to their supply in excess of requirement.
9. Though the cure rate under NTCP was between 17 and 29 per cent during 1996-97 to 2000-2001 against the cure rate of over 85 per cent envisaged under RNTCP, in 22 out of 23 districts the Programme has not been proposed for switch over to RNTCP in these districts. The percentage of defaulters in continued treatment steadily increased from 15 per cent in 1997-98 to 29 per cent in 2000-2001. The department had not analysed the reason for dismal cure rate and increasing trend of defaulters nor had taken any remedial measures to improve the position.